Disciplined Growth Investors Inc Red Hill Biopharma Ltd. Transaction History

Disciplined Growth Investors Inc

$4.73 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.58 $717,794 - $2.94 Million	-1,139,356 Reduced 58.43%	810,646 $705,000
Q1 2022 May 16, 2022	BUY	$1.65 - $3.12 $23,781 - $44,968	14,413 Added 0.74%	1,950,002 $4.91 Million
Q4 2021 Feb 14, 2022	SELL	$2.31 - $5.85 $94,448 - $239,188	-40,887 Reduced 2.07%	1,935,589 $4.99 Million
Q2 2021 Aug 16, 2021	BUY	$5.98 - $7.51 $884,376 - $1.11 Million	147,889 Added 8.09%	1,976,476 $13.6 Million
Q1 2021 May 17, 2021	SELL	$6.98 - $11.29 $1.4 Million - $2.26 Million	-200,608 Reduced 9.89%	1,828,587 $13.4 Million
Q4 2020 Feb 16, 2021	SELL	$7.81 - $10.39 $642,419 - $854,639	-82,256 Reduced 3.9%	2,029,195 $16.4 Million
Q3 2020 Nov 16, 2020	SELL	$6.34 - $10.83 $40,360 - $68,943	-6,366 Reduced 0.3%	2,111,451 $21.6 Million
Q2 2020 Aug 14, 2020	BUY	$4.6 - $8.6 $1.9 Million - $3.55 Million	413,328 Added 24.25%	2,117,817 $14.2 Million
Q1 2020 May 15, 2020	SELL	$3.51 - $6.17 $519,034 - $912,376	-147,873 Reduced 7.98%	1,704,489 $7.72 Million
Q4 2019 Feb 14, 2020	BUY	$5.76 - $7.35 $4.07 Million - $5.2 Million	707,348 Added 61.78%	1,852,362 $11.2 Million
Q3 2019 Nov 15, 2019	BUY	$6.46 - $8.37 $29,393 - $38,083	4,550 Added 0.4%	1,145,014 $8.06 Million
Q2 2019 Aug 14, 2019	SELL	$6.34 - $8.8 $60,046 - $83,344	-9,471 Reduced 0.82%	1,140,464 $7.41 Million
Q1 2019 May 14, 2019	BUY	$6.06 - $9.0 $42,020 - $62,406	6,934 Added 0.61%	1,149,935 $9.56 Million
Q4 2018 Feb 13, 2019	BUY	$5.18 - $9.35 $5.75 Million - $10.4 Million	1,109,567 Added 3318.68%	1,143,001 $6.34 Million
Q3 2018 Nov 16, 2018	BUY	$6.0 - $11.35 $200,604 - $379,475	33,434 New	33,434 $295,000

Others Institutions Holding RDHL

# of Institutions

Shares Held

40.4K

Call Options Held

Put Options Held

Eaton Vance Management Boston, MA

40.4K
Shares

$294,639
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About RedHill Biopharma Ltd.

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

More about RDHL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Growth Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Growth Investors Inc with notifications on news.

Account